Management of vertically HIV-infected children in Europe

Acta Paediatrica, International Journal of Paediatrics

Volumn 92, Issue 2, 2003, Pages 246-250

  Thorne, C ^a   Gray, L ^a   Newell, Marie Louise ^a,b   Giaquinto, C ^a   Ruga, E ^a   De Rossi, A ^a   Grosch Wurner I ^a,c   Mok, J ^a,d   Johnstone, F ^a,e   De Jose I ^a,f   Bates, I ^a,f   Hawkins, F ^a,f   Ladron De Guevara C ^a,f   Pena J M ^a,f   Gonzalez Garcia, J ^a,f   Arribas Lopez, J R ^a,f   Garcia Rodriguez, M C ^a,f   Asensi Botet, F ^a,g   Otero, M C ^a,g   Perez Tamarit D ^a,g   Ridaura, S ^a,g   Gregori, P ^a,g   De La Torre, R ^a,g   Scherpbier, H ^a,h   Kreyenbroek, M ^a,h   Boer, K ^a,h   Bohlin, A B ^a,i   Belfrage, E ^a,i   Naver L ^a,i   Levy, J ^a,j   Barlow, P ^a,j   Hainaut, M ^a,j   Peltier, A ^a,j   Wibaut, S ^a,j   Ferrazin, A ^a,k   Bassetti, D ^a,k   De Maria, A ^a,l   Gotta, C ^a,k   Mur A ^a,m   Paya A ^a,m   Vinolas M ^a,m   Lopez Vilchez M A ^a,m   Rovira, ^a,m   Carreras, R ^a,m   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f HOSPITAL INFANTIL LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^k UNIVERSITY OF GENOA   (Italy)

^l UNIVERSITY OF GENOA   (Italy)

^m UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

more..

Author keywords

Antiretroviral therapy; Europe; HIV infection; Policy; Practice

Indexed keywords

ANTIRETROVIRUS AGENT; NELFINAVIR; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EUROPE; FOLLOW UP; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LIPODYSTROPHY; LIVER INJURY; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; SYMPTOMATOLOGY; VERTICAL TRANSMISSION;

EID: 12244285640     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2003.tb00535.x     Document Type: Article

References (24)

1. Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA panel. JAMA 1997; 277: 1962-9
2. Nachman SA, Stanley K, Yogev R, Pelton S, Wiznia A, Lee S, et al. Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children. JAMA 2000; 283: 492-8
3. Funk MB, Linde R, Wintergerst U, Notheis G, Hoffman F, Schuster T, et al. Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children. AIDS 1999; 13: 1653-8
4. McKinney RE, Johnson GM, Stanley K, Yong FH, Keller A, O'Donnell KJ, et al. A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. J Pediatr. 1998; 133: 500-8
5. Englund JA, Baker CJ, Raskino C, McKinney RE, Petrie B, Fowler MG, et al. Zidovudine, didanosine or both as the initial treatment for symptomatic HIV-infected children. N Engl J Med 1997; 336: 1704-12
6. Kline MW, Fletcher CV, Harris AT, Evans KD, Brundage RC, Remmel RP, et al. A pilot study of combination therapy with indinavir, stavudine (d4T) and didanosine (ddI) in children infected with the human immunodeficiency virus. J Pediatr 1998; 132: 543-6
7. Italian Register for HIV Infection in Children Italian guidelines for antiretroviral therapy in children with human immunodeficiency virus-type 1 infection. Acta Pædiatr 1999; 88: 228-32
8. The Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. HIV/AIDS treatment information service. Available from URL: http://www.hivatis.org/trtgdlns.html# Pediatric
9. Stone VE, Mansourati FF, Poses RM, Mayer KH. Relation of physician speciality and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy. J Gen Intern Med 2001; 16: 360-8
10. European Collaborative Study. Fluctuations in symptoms in HIV-infected children: the first 10 years of life. Pediatrics 2001; 108: 116-22
11. Centers For Disease Control. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43: 1-10
12. Dunn D, Brandt CD, Krivine A, Cassol SA, Roques P, Borkowsky W, et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 1995; 9: F7-F11
13. Bernardi S, Thorne C, Newell ML, Giaquinto C, Tovo P-A, Rossi P. Variable use of therapeutic interventions for HIV-infected children in Europe. Eur J Pediatr 2000; 59: 70-5
14. Dominguez K, Peters V, Ortiz I, Frederick T, Rakusan T, Hsu H, et al. Antiretroviral therapy in perinatally HIV-infected infants, Pediatric Spectrum of HIV Disease Cohort, 1998-2000. 8th Conference on Retroviruses and Opportunistic Infections, 4-8 February 2001, Chicago: 2001; Abstract 647
15. Luzuriaga K, Bryson Y, Krogstad P, Robinson J, Stechenberg B, Lamson M, et al. Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection. N Engl J Med 1997; 336: 1343-9
16. Hainaut M, Peltier A, Gerard M, Marissens D, Zissis G, Levy J. Effectiveness of antiretroviral therapy initiated before the age of 2 months in infants vertically infected with human immunodeficiency virus type 1. Eur J Pediatr 2000; 159: 778-82
17. Albano F, Spagnuolo MI, Canani RB, Guarino A. Adherence to antiretroviral therapy in HIV-infected to children in Italy. AIDS Care 1999; 11: 711-4
18. Arpadi SM, Cuff PA, Horlick M, Wang J, Kotler DP. Lipodystrophy in HIV-infected children is associated with high viral load and low CD4 lymphocyte count and CD4 lymphocyte percentage at baseline and use of protease inhibitors and stavudine. J Acqu Immune Defic Synd Hum Retrovir 2001; 27: 30-4
19. European Collaborative Study. Level and pattern of HIV-1 RNA viral load over age: differences between girls and boys? AIDS 2002; 16: 97-104
20. PENTA guidelines on paediatric ART. PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. HIV Med 2002; 3: [in press]. Also available at http://www.ctu.mrc. ac.uk/penta/
21. Report of the results of PACTG 316: an international phase III trial of standard antiretroviral prophylaxis plus nevirapine for prevention of perinatal HIV transmission. Abstract LB7. 8th Conference on Retroviruses and Opportunistic Infections, Chicago, February 2001; 2001
22. Stephenson J. Sobering levels of drug-resistant HIV found. JAMA 2002; 287: 309-10
23. European Collaborative Study. HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS 2001; 15: 761-70
24. Kitahata MM, Koepssell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 1996; 334: 701-6